Newsfeeds - Spark Newswire

1 minute read

European Official Says COVID-19 Booster Uptake Disappointing In The Region

Today, 6:51 PM

Marco Cavaleri, the European Medicines Agency's (EMA) head of health threats and vaccines strategy, said the recent uptake of COVID-19 vaccine booster doses in the region has been "rather disappointing." The European average rate of receiving booster doses was only 29% in the groups considered to be at the highest risk.

AZN

2 minute read

CERENOVUS, Part Of Johnson & Johnson MedTech, Reveals Positive Outcomes With Thrombectomy In Global Registry Studying Stroke-Inducing Blood Clots

By Benzinga Newsdesk

Today, 6:51 PM

CERENOVUS, Inc., part of Johnson & Johnson MedTech*, today announced positive primary outcomes from the real-world EXCELLENT Registry focused on stroke inducing blood clot removal by mechanical thrombectomy at

JNJ

2 minute read

“Health And Human Services Report Says Mask Mandates Should Be Reinstated To Help ‘Long Covid'” – NYPost

By Benzinga Newsdesk

Today, 6:51 PM

Not this again. Masks and social distancing should be mandated or encouraged in public to protect people from possible “long COVID”, a new Department of Health and Human Services report

AHPI

1 minute read

White House Coronavirus Response Coordinator Ashish Kumar Jha Says Vaccines Effective Against New Coronavirus Subvariants

By Benzinga Newsdesk

Today, 6:51 PM

- Reuters

AZN

2 minute read

This Is What Whales Are Betting On Johnson & Johnson

By Benzinga Insights

Today, 6:51 PM

Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

JNJ

1 minute read

Analyst Expects Derisking Required Ahead Of Patent Expiry For This Large Pharma/MedTech Stock

By Vandana Singh

Today, 6:51 PM

Credit Suisse has initiated coverage on Johnson & Johnson (NYSE:JNJ) with a Neutral rating and a price target of $170. The…

JNJ

6 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For November 18, 2022

By Benzinga Insights

Today, 6:51 PM

Upgrades

ABBV

1 minute read

Analyst Ratings

Where Johnson & Johnson Stands With Analysts

By Benzinga Insights

Today, 6:51 PM

Analysts have provided the following ratings for Johnson & Johnson (NYSE:JNJ) within the last quarter: Bullish Somewhat Bullish…

JNJ

2 minute read

Flu Season Starts At Its Fastest Pace Since 2009 — Canada And Parts Of The U.S. Are Now Facing A Tylenol, Advil Shortage

By Robert Kuczmarski

Today, 6:51 PM

The U.S. flu season is already off to a fast start as children return to schools, less mask-wearing and travel returns to COVID-19 pre-pandemic norms.

JNJ

2 minute read

These 2 Dividend Paying ETFs Have A Track Record For Increasing Payments, Can Help Diversify Against Industry Risk

By Robert Kuczmarski

Today, 6:51 PM

Investing in an exchange-traded fund that invests in large cap dividend stocks can be a great way to secure passive income.

JNJ